LuciPem is indicated for the treatment of bile duct cancer
with FGFR gene alterations. It is a precision oncology medicine used globally.
Active Ingredient
Pemigatinib inhibits fibroblast growth factor receptors
(FGFR).
Uses of LuciPem
• Cholangiocarcinoma with FGFR mutation
How LuciPem Works
It blocks FGFR signaling pathways involved in tumor growth.
How to Use LuciPem
• Take as prescribed in cycles
Possible Side Effects
• Hyperphosphatemia
• Fatigue
• Dry mouth
Precautions
• Monitor phosphate levels
• Eye exams recommended
Safety Information
Regular monitoring required.
Storage
• Protect from moisture and sunlight
• Keep out of reach of children